Group 1: Marubi Biotechnology - Marubi Biotechnology is expanding its audience on Douyin through targeted content delivery, leading to an increase in its traffic pool [1] - The company is implementing organizational restructuring, optimizing its talent team, and upgrading its compensation management system to support growth [1] - The strategic investment in the second quarter is expected to convert significantly in the fourth quarter, with the "Lianhuo" brand entering a normal development phase and plans to continue launching new products in the second half of the year [1] - The three core product series account for over 70% of sales, indicating potential for further explosive growth [1] - The "Xiaojinzheng" series is enhancing customer purchase rates through synergistic effects, fostering consumption linkage between new and old customers [1] - The company is balancing investment in traffic and brand building while continuously promoting brand development [1] - The "Xiaohongbi" eye cream is performing exceptionally well in the market, with plans to gradually launch a series of products [1] - The company possesses core R&D capabilities and is leading the establishment of national industry standards for restructured collagen [1] Group 2: AVIC High-Tech - AVIC High-Tech is consolidating its main business while deepening its strategic layout in the low-altitude economy during the "14th Five-Year Plan" [2] - The company is advancing the research and industrialization of products such as honeycomb and composite structural components [2] - AVIC High-Tech has invested 9.17 billion in a project to enhance its capabilities in civil aviation composite components, specifically for large aircraft and G600 projects [2] - The Shenzhen subsidiary is collaborating with leading companies in the low-altitude economy, with some clients already initiating commercial operations [2] - The improvement in gross margin is attributed to changes in product structure, and new incubated businesses are expected to maintain reasonable gross margin levels [2] - The company anticipates significant improvement in cash collection in the second half of the year due to the maturity of bills received last year [2] - AVIC High-Tech is actively positioning itself in the large aircraft sector, with a significant expected increase in the application of composite materials [2] - R&D expenses have increased as projects are progressing as planned, with some costs being recognized in a timely manner [2]
【私募调研记录】呈瑞投资调研丸美生物、中航高科